3 results
Approved WMOCompleted
The aim of this phase IVI, randomized, open-label study is to compare the efficacy of cabazitaxel versus an AR targeted agent, in patients previously treated with docetaxel and likely to have primary resistance to AR targeted agents.
Approved WMORecruiting
The purpose of the study is to provide ongoing post-market demonstration of the safety and performance of the FARAPULSEPulsed Field Ablation System in the treatment of patients with paroxysmal atrial fibrillation (PAF).
Approved WMOPending
This IDE trial is proposed herein to gather clinical data on the safety and effectiveness of a hybridsinus node sparing ablation procedure utilizing the AtriCure ISOLATOR Synergy Surgical AblationSystem to obtain an IST indication.